NAS:PPBT (Israel)  
Purple Biotech Ltd logo

Purple Biotech Ltd

$ 1.93 +0.03 (+1.58%) 10:08 PM EST
P/E:
At Loss
P/B:
0.67
Market Cap:
$ 35.70M
Enterprise V:
$ 1.59M
Volume:
29.14K
Avg Vol (2M):
107.44K
Also Trade In:
Volume:
29.14K
Market Cap $:
35.70M
PE Ratio:
At Loss
Avg Vol (2-Month):
107.44K
Enterprise Value $:
1.59M
PB Ratio:
0.67
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Name Current Vs Industry Vs History
Cash-To-Debt 60.63
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 33.99
9-Day RSI 32.69
14-Day RSI 34.05
6-1 Month Momentum % -34.13
12-1 Month Momentum % -46.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.94
Quick Ratio 6.94
Cash Ratio 6.68

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -123.2
Name Current Vs Industry Vs History
ROE % -29.83
ROA % -27.33
ROIC % -74.68
ROC (Joel Greenblatt) % -2064.05
ROCE % -28.39

Financials (Next Earnings Date:2022-11-04 Est.)

PPBT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PPBT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.1
Beta 1.43
Volatility % 61.48
14-Day RSI 34.05
14-Day ATR ($) 0.13536
20-Day SMA ($) 2.138175
12-1 Month Momentum % -46.91
52-Week Range ($) 1.8325 - 4.75
Shares Outstanding (Mil) 18.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Purple Biotech Ltd Filings

Document Form Filing Date
No Filing Data

Purple Biotech Ltd Analysis

Share your research

Headlines

See More
No news.